Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy (vol 35, pg 709, 2017)

被引：2
|
作者：
Naidoo
Long, Georgina
Hellmann, Matthew
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 22期
关键词：
D O I：
10.1200/JCO.2017.74.5042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2590 / 2590
页数：1
相关论文
共 50 条
  • [31] Results of clinical trials with anti-programmed death 1/programmed death ligand 1 inhibitors in lung cancer
    Viteri, Santiago
    Gonzalez-Cao, Maria
    Barron, Feliciano
    Riso, Aldo
    Rosell, Rafael
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (06) : 756 - 762
  • [32] Programmed Death-Ligand 1 Expression and Response to the Anti-Programmed Death 1 Antibody Pembrolizumab in Melanoma
    Daud, Adil I.
    Wolchok, Jedd D.
    Robert, Caroline
    Hwu, Wen-Jen
    Weber, Jeffrey S.
    Ribas, Antoni
    Hodi, F. Stephen
    Joshua, Anthony M.
    Kefford, Richard
    Hersey, Peter
    Joseph, Richard
    Gangadhar, Tara C.
    Dronca, Roxana
    Patnaik, Amita
    Zarour, Hassane
    Roach, Charlotte
    Toland, Grant
    Lunceford, Jared K.
    Li, Xiaoyun Nicole
    Emancipator, Kenneth
    Dolled-Filhart, Marisa
    Kang, S. Peter
    Ebbinghaus, Scot
    Hamid, Omid
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (34) : 4102 - +
  • [33] Case Report: Complete Response of Primary Massive Hepatocellular Carcinoma to Anti-Programmed Death Ligand-1 Antibody Following Progression on Anti-Programmed Death-1 Antibody
    Liu, Gang
    Zhou, Wenxuan
    Li, Xiaoli
    Guo, Lijie
    He, Tingting
    Zhao, Juan
    Gong, Liansheng
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [34] Prognostic role of neutrophil to lymphocyte ratio in advanced melanoma treated with anti-programmed death-1 therapy
    Minowa, Tomoyuki
    Kato, Junji
    Hida, Tokimasa
    Horimoto, Kohei
    Sato, Sayuri
    Sawada, Masahide
    Uhara, Hisashi
    JOURNAL OF DERMATOLOGY, 2018, 45 (09): : E250 - E251
  • [35] Anti-programmed cell death-1 therapy in octogenarian and nonagenarian advanced/metastatic melanoma patients
    Cybulska-Stopa, Bozena
    Zietek, Marcin
    Kaminska-Winciorek, Grazyna
    Czarnecka, Anna M.
    Piejko, Karolina
    Galus, Lukasz
    Ziolkowska, Barbara
    Kieszko, Stanislaw
    Kempa-Kaminska, Natasza
    Calik, Jacek
    Zemelka, Tomasz
    Kubiatowski, Tomasz
    Suwinski, Rafal
    Mackiewicz, Jacek
    Rutkowski, Piotr
    MELANOMA RESEARCH, 2021, 31 (01) : 49 - 57
  • [36] Targeting the programmed death-1/programmed death-ligand 1 axis in lymphoma
    Cheah, Chan Yoon
    Fowler, Nathan H.
    Neelapu, Sattva S.
    CURRENT OPINION IN ONCOLOGY, 2015, 27 (05) : 384 - 391
  • [37] Re-immunotherapy with nivolumab plus ipilimumab in advanced non-small cell lung cancer patients previously treated with anti-programmed death-1 and/or anti-programmed death ligand-1 antibodies
    Takuma Imakita
    Kohei Fujita
    Takanori Ito
    Zentaro Saito
    Issei Oi
    Osamu Kanai
    Hiromasa Tachibana
    Satoru Sawai
    Tadashi Mio
    Discover Oncology, 14
  • [38] Re-immunotherapy with nivolumab plus ipilimumab in advanced non-small cell lung cancer patients previously treated with anti-programmed death-1 and/or anti-programmed death ligand-1 antibodies
    Imakita, Takuma
    Fujita, Kohei
    Ito, Takanori
    Saito, Zentaro
    Oi, Issei
    Kanai, Osamu
    Tachibana, Hiromasa
    Sawai, Satoru
    Mio, Tadashi
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [39] Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy
    Rosenberg, Jonathan E.
    O'Donnell, Peter H.
    Balar, Arjun, V
    McGregor, Bradley A.
    Heath, Elisabeth, I
    Yu, Evan Y.
    Galsky, Matthew D.
    Hahn, Noah M.
    Gartner, Elaina M.
    Pinelli, Juan M.
    Liang, Shang-Ying
    Melhem-Bertrandt, Amal
    Petrylak, Daniel P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (29) : 2592 - +
  • [40] Fulminant type1 diabetes mellitus with anti-programmed cell death-1 therapy
    Okamoto, Masahide
    Okamoto, Mitsuhiro
    Gotoh, Koro
    Masaki, Takayuki
    Ozeki, Yoshinori
    Ando, Hisae
    Anai, Manabu
    Sato, Asami
    Yoshida, Yuichi
    Ueda, So
    Kakuma, Tetsuya
    Shibata, Hirotaka
    JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (06) : 915 - 918
12345